284 related articles for article (PubMed ID: 31977248)
1. Identification of
Zhao S; Yu M
DNA Cell Biol; 2020 Feb; 39(2):255-272. PubMed ID: 31977248
[TBL] [Abstract][Full Text] [Related]
2. Identification of Key Genes in Association with Progression and Prognosis in Cervical Squamous Cell Carcinoma.
Meng H; Liu J; Qiu J; Nie S; Jiang Y; Wan Y; Cheng W
DNA Cell Biol; 2020 May; 39(5):848-863. PubMed ID: 32202912
[TBL] [Abstract][Full Text] [Related]
3. Integrated bioinformatics combined with machine learning to analyze shared biomarkers and pathways in psoriasis and cervical squamous cell carcinoma.
Liu L; Yin P; Yang R; Zhang G; Wu C; Zheng Y; Wu S; Liu M
Front Immunol; 2024; 15():1351908. PubMed ID: 38863714
[TBL] [Abstract][Full Text] [Related]
4. Identification of EPHX2 and RMI2 as two novel key genes in cervical squamous cell carcinoma by an integrated bioinformatic analysis.
Liu J; Nie S; Gao M; Jiang Y; Wan Y; Ma X; Zhou S; Cheng W
J Cell Physiol; 2019 Nov; 234(11):21260-21273. PubMed ID: 31041817
[TBL] [Abstract][Full Text] [Related]
5. POLE2 Serves as a Prognostic Biomarker and Is Associated with Immune Infiltration in Squamous Cell Lung Cancer.
Wu Z; Wang YM; Dai Y; Chen LA
Med Sci Monit; 2020 Apr; 26():e921430. PubMed ID: 32304567
[TBL] [Abstract][Full Text] [Related]
6. Differentially expressed EREG and SPP1 are independent prognostic markers in cervical squamous cell carcinoma.
Zhang L; Nan F; Yang L; Dong Y; Tian Y
J Obstet Gynaecol Res; 2022 Jul; 48(7):1848-1858. PubMed ID: 35491469
[TBL] [Abstract][Full Text] [Related]
7. Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.
Feng S; Wang Z; Zhang H; Hou B; Xu Y; Hao S; Lu Y
J Gene Med; 2024 Jan; 26(1):e3643. PubMed ID: 38044747
[TBL] [Abstract][Full Text] [Related]
8. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
9. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F
Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732
[TBL] [Abstract][Full Text] [Related]
11. The matrix metalloproteinase gene family: a significant prognostic gene lineage correlated with immune infiltrates in laryngeal squamous cell carcinoma.
Yang C; Cao H; Yang JW; Liu T; Wang JT; Wang BS
Neoplasma; 2021 Nov; 68(6):1212-1224. PubMed ID: 34585589
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance of interleukin 24 and its potential molecular mechanism in laryngeal squamous cell carcinoma.
Tang XZ; Zhou XG; Zhang XG; Li GS; Chen G; Dang YW; Huang ZG; Li MX; Liang Y; Yao YX; Chen XY; Rong MH; Huang SN
Cancer Biomark; 2020; 29(1):111-124. PubMed ID: 32623386
[TBL] [Abstract][Full Text] [Related]
13. Uncovering of potential molecular markers for cervical squamous cell carcinoma (CESC) based on analysis of methylated-differentially expressed genes.
Liu M; Wei D; Nie Q; Peng L; He L; Cui Y; Ye Y
Taiwan J Obstet Gynecol; 2022 Jul; 61(4):663-671. PubMed ID: 35779918
[TBL] [Abstract][Full Text] [Related]
14. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
[TBL] [Abstract][Full Text] [Related]
15. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Sun K; Huang C; Li JZ; Luo ZX
World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
[TBL] [Abstract][Full Text] [Related]
16. Prognostic alternative splicing signature in cervical squamous cell carcinoma.
Wu HY; Li QQ; Liang L; Qiu LL; Wei HW; Huang BY; Gang- C; He RQ; Huang ZG; Hou W; Hu QP; Pan SL
IET Syst Biol; 2020 Dec; 14(6):314-322. PubMed ID: 33399095
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase 1: a better biomarker for squamous cell carcinoma by multiple microarray analyses.
Zheng LQ; Wang R; Chi SM; Li CX
G Ital Dermatol Venereol; 2019 Jun; 154(3):327-337. PubMed ID: 29249121
[TBL] [Abstract][Full Text] [Related]
18. Identification of a six-gene prognostic signature for oral squamous cell carcinoma.
Wang J; Wang Y; Kong F; Han R; Song W; Chen D; Bu L; Wang S; Yue J; Ma L
J Cell Physiol; 2020 Mar; 235(3):3056-3068. PubMed ID: 31538341
[TBL] [Abstract][Full Text] [Related]
19. Prediction of a miRNA-mRNA functional synergistic network for cervical squamous cell carcinoma.
Sun D; Han L; Cao R; Wang H; Jiang J; Deng Y; Yu X
FEBS Open Bio; 2019 Dec; 9(12):2080-2092. PubMed ID: 31642613
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of gastric cancer-associated gene signatures: Evidence based on a meta-analysis using integrated bioinformatics methods.
Wang J; Gao P; Song Y; Sun J; Chen X; Yu H; Wang Y; Wang Z
J Cell Mol Med; 2018 Nov; 22(11):5743-5747. PubMed ID: 30133128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
